Hepatic and cardiac necrosis in a patient with prostatic carcinoma given -aminocaproic acid
Open Access
- 1 January 1963
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 16 (1) , 61-64
- https://doi.org/10.1136/jcp.16.1.61
Abstract
The pathological findings in a case of prostatic carcinoma with fibrinolysin, treated with ε-aminocaproic acid, included hepatic and cardiac necrosis. The possibility is discussed that the latter lesions may be a complication of ε-aminocaproic acid therapy or produced by the proteolytic action of the fibrinolysin.Keywords
This publication has 9 references indexed in Scilit:
- Clinical Experiences with ε‐Aminocaproic Acid (ε‐ACA) as an Antifibrinolytic AgentActa Medica Scandinavica, 1961
- ANTIFIBRINOLYTIC ACTIVITY AND METABOLISM OF Σ-AMINOCAPROIC ACID IN MANThe Lancet, 1960
- Fibrinolysis and Fibrinolytic Activity in ManPhysiological Reviews, 1959
- THE USE OF PLASMIN IN THE TREATMENT OF INTRAVASCULAR THROMBOSES††Journal of the American Geriatrics Society, 1958
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956
- FACTOR 5 DEFICIENCY IN HEMORRHAGIC DIATHESIS (PARAHEMOPHILIA)JAMA, 1952
- ACTIVITY OF PLASMA LABILE FACTOR IN DISEASEThe Lancet, 1951
- FORMATION OF BRADYKININ IN ANAPHYLACTIC AND PEPTONE SHOCKAmerican Journal of Physiology-Legacy Content, 1950
- The Diagnostic and Prognostic Significance of Plasma Prothrombin and Factor V Levels in Parenchymatous Hepatitis and Obstructive JaundiceScandinavian Journal of Clinical and Laboratory Investigation, 1949